Wednesday, August 26, 2026

M&A Activity

2 articles

TPG Cuts Private Equity Exposure to 45% of AUM as Firms Rush Into Credit Markets

TPG Cuts Private Equity Exposure to 45% of AUM as Firms Rush Into Credit Markets

TPG reduced its private equity allocation from 80% to 45% of assets under management while raising over $20 billion in credit strategies, marking a dramatic shift in asset manager positioning. Third Point launched a new private credit pooled fund as firms pivot toward lending markets. The strategic realignment comes as PE deal activity continues with notable transactions including bids for Papa John's and the F&G Life Re acquisition.

LM Salvado
EQT Infrastructure and Energy Capital Partners Lead $10B+ AES Acquisition Amid Private Equity Rush to Energy Assets

EQT Infrastructure and Energy Capital Partners Lead $10B+ AES Acquisition Amid Private Equity Rush to Energy Assets

A private equity consortium led by EQT Infrastructure and Energy Capital Partners is acquiring AES Corporation in a landmark energy infrastructure deal. The transaction anchors a broader wave of PE dealmaking spanning healthcare, beverages, and financial services, with multiple tender offers underway. PE firms appear to be positioning ahead of predicted equity market corrections.

ViaNews Editorial Team (Markets)
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com